David Cunningham
Royal Marsden NHS Foundation Trust · 1,828 works · 123,803 citations · h-index 147
Top works
- Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
- Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer
- Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial
- Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer
- Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
- Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer
- A Prognostic Score for Advanced Hodgkin's Disease
- Kirsten ras Mutations in Patients With Colorectal Cancer: the Multicenter "RASCAL" Study
- Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
- Panitumumab–FOLFOX4 Treatment and RAS Mutations in Colorectal Cancer
- Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status
- Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.
- Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study
- Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial
- Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection
- Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastases
- Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial
- Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- European Phase II Study of Rituximab (Chimeric Anti-CD20 Monoclonal Antibody) for Patients With Newly Diagnosed Mantle-Cell Lymphoma and Previously Treated Mantle-Cell Lymphoma, Immunocytoma, and Small B-Cell Lymphocytic Lymphoma
- Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up